Grapiprant
N/A
Report date: 2026/03/12 20:00:16
NME
Base Information
Drug NameGrapiprant
Drug Alias Name +[14]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[10]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShangHai HaiHe Biopharma Co Ltd
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active Companies3d Medicines IncEli Lilly And CompanyArrys Therapeutics Inc +[7]
Inactive CompaniesPfizer IncThe University Of Texas MD Anderson Cancer CenterUniversity Of Maryland, Baltimore +[5]
Active Indications
Inactive Indications +[7]
Other Information
ATC CodeN/A
Related LinksKEGG